Affiliation:
1. Guizhou University of Traditional Chinese Medicine
2. The First Clinical Medical School of Guangzhou University of Chinese Medicine
3. the first affiliated hospital of Guangzhou University of Traditional Chinese Medicine
Abstract
Abstract
Background
Non-Hodgkin's lymphoma incidence rates vary between European and Asian populations. The reasons remain unclear. This two-sample two-step Mendelian randomisation (MR) study aimed to investigate the causal relationship between anthropometric indicators (AIs) and diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) and the possible mediating role of basal metabolic rate (BMR) in Europe. (2)
Methods
We used the following AIs as exposures: body mass index (BMI), whole-body fat mass (WBFM), whole-body fat-free mass (WBFFM), waist circumference(WC), hip circumference(HC), standing height (SH), and weight(Wt). DLBCL and FL represented the outcomes, and BMR was a mediator. A two-sample MR analysis was performed to examine the association between AIs and DLBCL and FL onset. We performed reverse-MR analysis to determine whether DLBCL and FL interfered with the AIs. A two-step MR analysis was performed to determine whether BMR mediated the causality. (3) Findings: WBFFM and SH had causal relationships with FL. A causal association between AIs and DLBCL was not observed. Reverse-MR analysis indicated the causal relationships were not bidirectional. Two-step MR suggested BMR may mediate the causal effect of WBFFM and SH on FL. (4)
Conclusions
We observed a causal relationship between WBFFM and SH and the onset of FL in Europeans, Which may explain the high incidence of follicular lymphoma in Europeans.
Publisher
Research Square Platform LLC
Reference100 articles.
1. Non-Hodgkin lymphoma;Shankland KR;Lancet (London, England),2012
2. Epidemiology of Non-Hodgkin's Lymphoma;Thandra KC;Medical sciences (Basel, Switzerland),2021
3. Incidence of second primary malignancies in relapsed/refractory B-cell non-Hodgkin's lymphoma patients in England;Miret M;Leukemia research,2023
4. Follicular lymphoma: Update on management and emerging therapies at the dawn of the new decade;Apostolidis J;Hematological oncology,2020
5. Susanibar-Adaniya, S. & Barta, S. K. 2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management. American journal of hematology 96, 617–629, doi:10.1002/ajh.26151 (2021).